Treatment outcome of all-trans retinoic acid/anthracycline combination chemotherapy and the prognostic impact of FLT3/ITD mutation in acute promyelocytic leukemia patients

BACKGROUND: All-trans retinoic acid (ATRA)/anthracycline chemotherapy is beneficial in newly diagnosed acute promyelocytic leukemia (APL); however, it is important to identify patients with high-risk disease to increase the cure rate. We investigated the outcome of ATRA/anthracycline chemotherapy an...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Seung-Dok, Kim, Yeo-Kyeoung, Kim, Hee-Nam, Lee, Se Ryeon, Ahn, Jae-Sook, Yang, Deok-Hwan, Lee, Je-Jung, Lee, Il-Kwon, Shin, Myung-Geun, Kim, Hyeoung-Joon
Formato: Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3065622/
https://www.ncbi.nlm.nih.gov/pubmed/21461300
http://dx.doi.org/10.5045/kjh.2011.46.1.24

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3065622/
https://www.ncbi.nlm.nih.gov/pubmed/21461300
http://dx.doi.org/10.5045/kjh.2011.46.1.24

Ejemplares similares